AzTrials
AzTrials

Skeletal Class III DeformityOrthognathicNCT07595978

Soft Tissue Changes After Orthognathic Surgery

A study testing Minimally Invasive Bimaxillary Orthognathic Surgery and Conventional Bimaxillary Orthognathic Surgery in people with Skeletal Class III Deformity, run by TC Erciyes University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluated postoperative soft tissue changes in skeletal Class III patients following minimally invasive and conventional orthognathic surgery using three-dimensional stereophotogrammetric analysis. Read more about this study

Who is it for?
Ages 17 to 36 years
Conditions the study is for
Skeletal Class III Deformity
What is being tested?
Minimally Invasive Bimaxillary Orthognathic Surgery and Conventional Bimaxillary Orthognathic Surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Jan 2025to 10 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 36 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Skeletal Class III patients requiring bimaxillary orthognathic surgery Patients treated with minimally invasive or conventional orthognathic surgery Availability of high-resolution three-dimensional stereophotogrammetric images obtained preoperatively and at least 6 months postoperatively Patients with complete clinical records Completion of craniofacial growth Patients with less than 10 mm maxillary advancement/setback

Who cannot join

  • Craniofacial syndromes or congenital anomalies History of previous orthognathic surgery Facial trauma affecting soft tissue morphology Incomplete clinical or imaging records Systemic diseases affecting soft tissue healing or craniofacial morphology

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Erciyes University Faculty of Dentistry Department of Orthodontics

    Kayseri, Kayseri, 38000

Other trials in Turkey (Türkiye)

About this study

Official title: Three-Dimensional Stereophotogrammetric Analysis of Soft Tissue Changes Following Minimally Invasive Versus Conventional Orthognathic Surgery in Skeletal Class III Patients

This study evaluated postoperative soft tissue changes in skeletal Class III patients following minimally invasive and conventional orthognathic surgery using three-dimensional stereophotogrammetric analysis.

Read the detailed description

This study was conducted on 31 adult patients who underwent bimaxillary orthognathic surgery. Patients were divided into minimally invasive (n=15; mean age: 23.2 years) and conventional surgery groups (n=16; mean age: 22.4 years) according to the surgical technique performed. High-resolution three-dimensional stereophotogrammetric facial images were obtained preoperatively (T0) and at least six months postoperatively (T1). Three-dimensional displacements of soft tissue anthropometric landmarks, as well as linear and angular measurements, were analyzed. Data distribution was assessed using the Shapiro-Wilk test, and appropriate parametric and non-parametric tests were used for intra- and intergroup comparisons. Statistical significance was set at p<0.05.

Being tested
Minimally Invasive Bimaxillary Orthognathic Surgery, Conventional Bimaxillary Orthognathic Surgery
Keywords
Bimaxillary orthognathic surgery, Minimally invasive technique, Skeletal Class III, Stereophotogrammetry

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Minimally Invasive Bimaxillary Orthognathic SurgeryProcedure or surgery

    Bimaxillary orthognathic surgery performed using a minimally invasive surgical approach characterized by limited soft tissue dissection, reduced surgical exposure, and preservation of vascular integrity to minimize postoperative soft tissue alterations.

  • Conventional Bimaxillary Orthognathic SurgeryProcedure or surgery

    Bimaxillary orthognathic surgery performed using conventional surgical exposure and standard soft tissue dissection techniques.

Study groups in NCT07595978
Study groupRoleWhat they receive
Minimally Invasive Orthognathic SurgeryExperimentalSkeletal Class III patients treated with minimally invasive bimaxillary orthognathic surgery characterized by reduced soft tissue dissection, limited surgical exposure, and preservation of vascular integrity compared with the conventional approach. This technique aims to minimize postoperative soft tissue alterations and improve postoperative recovery. Soft tissue changes were evaluated using three-dimensional stereophotogrammetric analysis.
Receives: Procedure: Minimally Invasive Bimaxillary Orthognathic Surgery
Conventional Orthognathic SurgeryActive comparatorSkeletal Class III patients treated with conventional bimaxillary orthognathic surgery. Postoperative soft tissue changes were evaluated using three-dimensional stereophotogrammetric analysis.
Receives: Procedure: Conventional Bimaxillary Orthognathic Surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Three-Dimensional Soft Tissue Landmark Displacements

    Three-dimensional soft tissue landmark displacements (mm) evaluated using stereophotogrammetric analysis in skeletal Class III patients undergoing minimally invasive and conventional bimaxillary orthognathic surgery.

    Measured: Up to 6 months

  2. Linear Soft Tissue Measurements

    Linear soft tissue measurements (mm) evaluated using stereophotogrammetric analysis in skeletal Class III patients undergoing minimally invasive and conventional bimaxillary orthognathic surgery.

    Measured: Up to 6 months

  3. Angular Soft Tissue Measurements

    Angular soft tissue measurements (degree) evaluated using stereophotogrammetric analysis in skeletal Class III patients undergoing minimally invasive and conventional bimaxillary orthognathic surgery.

    Measured: Up to 6 months

Secondary outcomes (2)
  1. Airway Measurements

    Airway measurements (mm) evaluated using cephalometric analysis in skeletal Class III patients undergoing minimally invasive and conventional bimaxillary orthognathic surgery.

    Measured: Up to 6 months

  2. Lip Thickness Measurements

    Upper and lower lip thickness measurements (mm) evaluated using three-dimensional stereophotogrammetric analysis in skeletal Class III patients undergoing minimally invasive and conventional bimaxillary orthognathic surgery.

    Measured: Up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2026
  2. Study start2 Jan 2025
  3. Primary completion1 Mar 2025
  4. Study completion10 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
This study was conducted on 31 adult patients who underwent bimaxillary orthognathic surgery. Patients were divided into minimally invasive (n=15; mean age: 23.2 years) and conventional surgery groups (n=16; mean age: 22.38 years) according to the surgical technique performed. High-resolution three-dimensional stereophotogrammetric facial images were obtained preoperatively (T0) and at least six months postoperatively (T1). Three-dimensional displacements of soft tissue anthropometric landmarks, as well as linear and angular measurements, were analyzed. Data distribution was assessed using the Shapiro-Wilk test, and appropriate parametric and non-parametric tests were used for intra- and intergroup comparisons. Statistical significance was set at p\<0.05.
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07595978
Sponsor's protocol ID
TDH-2024/305
Acronym
Orthognathic
Status last verified
May 2026
First submitted
10 May 2026
Last updated
19 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Weinberg SM. 3D stereophotogrammetry versus traditional craniofacial anthropometry: Comparing measurements from the 3D facial norms database to Farkas's North American norms. Am J Orthod Dentofacial Orthop. 2019 May;155(5):693-701. doi: 10.1016/j.ajodo.2018.06.018.

    PubMed 31053285
  • Dinu C, Manea A, Tomoiaga D, Baciut M, Almasan O, Mitre AO, Barbur I, Hedesiu M, Armencea G, Opris H, Stoia S, Tamas T, Baciut G, Onisor F, Bran S. Recovery following Orthognathic Surgery Procedures-A Pilot Study. Int J Environ Res Public Health. 2022 Nov 30;19(23):16028. doi: 10.3390/ijerph192316028.

    PubMed 36498101
  • Ajmera DH, Singh P, Leung YY, Gu M. Three-dimensional evaluation of soft-tissue response to osseous movement after orthognathic surgery in patients with facial asymmetry: A systematic review. J Craniomaxillofac Surg. 2021 Sep;49(9):763-774. doi: 10.1016/j.jcms.2021.04.010. Epub 2021 Apr 24.

    PubMed 34016501

Questions about this trial

What is this clinical trial studying?

A study testing Minimally Invasive Bimaxillary Orthognathic Surgery and Conventional Bimaxillary Orthognathic Surgery in people with Skeletal Class III Deformity, run by TC Erciyes University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Three-Dimensional Soft Tissue Landmark Displacements (time frame: Up to 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07595978, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in